Retrospective utility of bronchoscopy after hematopoietic stem cell transplant

Bone Marrow Transplantation

Volumn 38, Issue 10, 2006, Pages 693-698

  Hofmeister, C C ^a   Czerlanis, C ^b   Forsythe, S ^b   Stiff, P J ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; FLUCONAZOLE; IMIPENEM; ITRACONAZOLE; NORFLOXACIN; VALACICLOVIR;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION; BRONCHUS BIOPSY; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DRUG SUBSTITUTION; FEBRILE NEUTROPENIA; FEMALE; FIBEROPTIC BRONCHOSCOPY; GRAM NEGATIVE BACTERIUM; HEALTH CARE UTILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES SIMPLEX; HOSPITAL PATIENT; HUMAN; LUNG INFILTRATE; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; PSEUDOMONAS INFECTIONS; RETROSPECTIVE STUDIES;

EID: 33750545588     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705505     Document Type: Article

References (36)

1. Krowka MJ, Rosenow III EC, Hoagland HC. Pulmonary complications of bone marrow transplantation. Chest 1985; 87: 237-246.
2. Roy V, Ali LI, Selby GB. Routine chest radiography for the evaluation of febrile neutropenic patients after autologous stem cell transplantation. Am J Hematol 2000; 64: 170-174.
3. Heussel CP, Kauczor HU, Heussel GE, Fischer B, Begrich M, Mildenberger P et al. Pneumonia in febrile neutropenic patients and in bone marrow and blood stem-cell transplant recipients: Use of high-resolution computed tomography. J Clin Oncol 1999; 17: 796-805.
4. Shorr AF, Susla GM, O'Grady NP. Pulmonary infiltrates in the non-HIV-infected immunocompromised patient: Etiologies, diagnostic strategies, and outcomes. Chest 2004; 125: 260-271.
5. Dunagan DP, Baker AM, Hurd DD, Haponik EF. Bronchoscopic evaluation of pulmonary infiltrates following bone marrow transplantation. Chest 1997; 111: 135-141.
6. Feinstein MB, Mokhtari M, Ferreiro R, Stover DE, Jakubowski A. Fiberoptic bronchoscopy in allogeneic bone marrow transplantation: findings in the era of serum cytomegalovirus antigen surveillance. Chest 2001; 120: 1094-1100.
7. Glazer M, Breuer R, Berkman N, Lossos IS, Kapelushnik J, Nagler A et al. Use of fiberoptic bronchoscopy in bone marrow transplant recipients. Acta Haematologica 1998; 99: 22-26.
8. Patel NR, Lee PS, Kim JH, Weinhouse GL, Koziel H. The influence of diagnostic bronchoscopy on clinical outcomes comparing adult autologous and allogeneic bone marrow transplant patients. Chest 2005; 127: 1388-1396.
9. White P, Bonacum JT, Miller CB. Utility of fiberoptic bronchoscopy in bone marrow transplant patients. Bone Marrow Transplant 1997; 20: 681-687.
10. Dykewicz CA. Summary of the guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Clin Infect Dis 2001; 33: 139-144.
11. Goodrich JM, Bowden RA, Fisher L, Keller C, Schoch G, Meyers JD. Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant. Ann Intern Med 1993; 118: 173-178.
12. Lyytikainen O, Ruutu T, Volin L, Lautenschlager I, Jokipii L, Tiittanen L et al. Late onset Pneumocystis carinii pneumonia following allogeneic bone marrow transplantation. Bone Marrow Transplant 1996; 17: 1057-1059.
13. Sakamaki H, Yuasa K, Goto H, Tanikawa S, Akiyama H, Onozawa Y et al. Comparison of cytomegalovirus (CMV) antigenemia and CMV in bronchoalveolar lavage fluid for diagnosis of CMV pulmonary infection after bone marrow transplantation. Bone Marrow Transplant 1997; 20: 143-147.
14. Winston DJ, Ho WG, Bartoni K, Du Mond C, Ebeling DF, Buhles WC et al. Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial. Ann Intern Med 1993; 118: 179-184.
15. Goldstein RA, Rohatgi PK, Bergofsky EH, Block ER, Daniele RP, Dantzker DR et al. Clinical role of bronchoalveolar lavage in adults with pulmonary disease. Am Rev Respir Dis 1990; 142: 481-486.
16. Gaviria JM, Garcia PJ, Garrido SM, Corey L, Boeckh M. Nontuberculous mycobacterial infections in hematopoietic stem cell transplant recipients: Characteristics of respiratory and catheter-related infections. Biol Blood Marrow Transplant 2000; 6: 361-369.
17. Yu VL, Muder RR, Poorsattar A. Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results from a three-year prospective study. Am J Med 1986; 81: 249-254.
18. Reichenberger F, Habicht J, Matt P, Frei R, Soler M, Bolliger CT et al. Diagnostic yield of bronchoscopy in histologically proven invasive pulmonary aspergillosis. Bone Marrow Transplant 1999; 24: 1195-1199.
19. European Organization for Research and Treatment of Cancer Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group. Proposed Definitions of Invasive Fungal Infections, 2004 (cited; available from: www.aspergillus.man.ac.uk).
20. McLintock LA, Holyoake TL, Jones BL. Published rather than proposed definitions for invasive fungal infection must be applied to allow standardization in clinical trials. Clin Infect Dis 2004; 38: 1648-1649.
21. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus. Clin Infect Dis 2002; 34: 7-14.
22. Davis KA. Ventilator-associated pneumonia: A review. J Intensive Care Med 2006; 21: 211-226.
23. Rano A, Agusti C, Jimenez P, Angrill J, Benito N, Danes C et al. Pulmonary infiltrates in non-HIV immunocompromised patients: A diagnostic approach using non-invasive and bronchoscopic procedures. Thorax 2001; 56: 379-387.
24. Pene F, Aubron C, Azoulay E, Blot F, Thiery G, Raynard B et al. Outcome of critically ill allogeneic hematopoietic stemcell transplantation recipients: A reappraisal of indications for organ failure supports. J Clin Oncol 2006; 24: 643-649.
25. Khassawneh BY, White Jr P, Anaissie EJ, Barlogie B, Hiller FC. Outcome from mechanical ventilation after autologous peripheral blood stem cell transplantation. Chest 2002; 121: 185-188.
26. Singh N, Paterson DL. Aspergillus infections in transplant recipients. Clin Microbiol Rev 2005; 18: 44-69.
27. Horvath JA, Dummer S. The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis. Am J Med 1996; 100: 171-178.
28. Marr KA, Balajee SA, McLaughlin L, Tabouret M, Bentsen C, Walsh TJ. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: Variables that affect performance. J Infect Dis 2004; 190: 641-649.
29. Rovira M, Jimenez M, De La Bellacasa JP, Mensa J, Rafel M, Ortega M et al. Detection of Aspergillus galactomannan by enzyme immunoabsorbent assay in recipients of allogeneic hematopoietic stem cell transplantation: A prospective study. Transplantation 2004; 77: 1260-1264.
30. Musher B, Fredricks D, Leisenring W, Balajee SA, Smith C, Marr KA. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. J Clin Microbiol 2004; 42: 5517-5522.
31. Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: Changes in epidemiology and risk factors. Blood 2002; 100: 4358-4366.
32. Soubani AO, Qureshi MA, Baynes RD. Flexible bronchoscopy in the diagnosis of pulmonary infiltrates following autologous peripheral stem cell transplantation for advanced breast cancer. Bone Marrow Transplant 2001; 28: 981-985.
33. Todd NW, Peters WP, Ost AH, Roggli VL, Piantadosi CA. Pulmonary drug toxicity in patients with primary breast cancer treated with high-dose combination chemotherapy and autologous bone marrow transplantation. Am Rev Respir Dis 1993; 147: 1264-1270.
34. Wilczynski SW, Erasmus JJ, Petros WP, Vredenburgh JJ, Folz RJ. Delayed pulmonary toxicity syndrome following high-dose chemotherapy and bone marrow transplantation for breast cancer. Am J Respir Crit Care Med 1998; 157: 565-573.
35. CIBMTR Data. Indications for Blood and Marrow Transplantation in North America, 2002. www.marrow.org, 2002.
36. Huaringa AJ, Leyva FJ, Signes-Costa J, Morice RC, Raad I, Darwish AA et al. Bronchoalveolar lavage in the diagnosis of pulmonary complications of bone marrow transplant patients. Bone Marrow Transplant 2000; 25: 975-979.